socalTECH
OCTOBER 5, 2015
Thousand Oaks-based Teledyne Technologies said this morning that it is cutting its outlook for the third quarter and full year, due to decline in sales in energy-related products. The company also blamed a strong U.S. dollar and "challenging" capital spending environment impacting its results.
socalTECH
APRIL 22, 2009
Thousand Oaks-based Teledyne Technologies , an aerospace and electronics firm, announced Wednesday that the firm has cut six percent of its North American workforce, eliminated salary increases, cut employee stock option awards, and will also close or relocate five of its operating sites, as it looks to cut expenses.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
socalTECH
FEBRUARY 20, 2009
Think the IPO market is dead? Apparently, firms are still hoping the market will open up for initial public offerings, with 57 companies nationwide still in registration for an IPO, as of the end of December. Tags: california merger acquisition southern market.
socalTECH
OCTOBER 29, 2015
I grew up in Thousand Oaks, went to USC, and we met each other way back in the 90's. The easiest way to look at it, from the tech perspective, is that we are very similar to LendingClub. We said, let's create a technology marketplace and platform that creates benefits for those existing lenders, as well as investors.
SoCal Delicious
APRIL 5, 2010
Home About Us Newsstand locations Special Section Nominations Stock Index Advertising Contact Search Subscribe Weekly Features Week in Review Top 25 Lists Top Stories Local News Opinion Calendar Ongoing Events Monthly Reports Central Coast East Ventura Nonprofits Technology Small Business Women and Co.
socalTECH
APRIL 29, 2014
They wanted to do 3-D X-rays, but at the time, there was not technology available to do that. Unfortunately, UCLA''s money dried up due to legal issues. The concept of the incubator is we''re raising a fund here locally and ten percent is local the other 90 percent on AngelList, and we''ll be locating here in the town of Thousand Oaks.
Xconomy
AUGUST 5, 2016
As a result, Biogen will buy the rights to nusinersen and prepare to ask regulators for marketing approval. Published in January, the technology comes from the lab of Keith Joung, who is an Editas cofounder. SMA has no approved treatments. —Meanwhile, scientists from San Diego-based Synthetic Genomics and the J.
Expert insights. Personalized for you.
100 
Let's personalize your content